Cyfendus Market Report 2026

Cyfendus Market Overview

• The Cyfendus market growth in the historic period has been driven by bioterrorism preparedness initiatives, prior anthrax exposure incidents • Market expansion is supported by heightened biodefense investments, expansion of emergency response frameworks • Growth Driver: Rising Anthrax Incidence Driving Growth In Cyfendus Market • Market Trend: Innovative Solutions For Anthrax Protection In High-Risk Environments • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cyfendus Market?

Cyfendus is a branded intramuscular vaccine that contains anthrax vaccine adsorbed and adjuvanted, designed for protection against anthrax infections. It is designed to prevent anthrax infection caused by Bacillus anthracis, typically following potential exposure. The vaccine stimulates the body to produce protective antibodies against the anthrax bacteria. It is generally administered in conjunction with antibiotics as part of a post-exposure prophylaxis regimen to reduce the risk of developing the disease. The main routes of administration for cyfendus include parenteral and oral. Parenteral refers to the administration of medications or nutrients by any route other than the digestive tract, typically through injection or infusion. It is used for pre-exposure prophylaxis, post-exposure prophylaxis, and special populations and is distributed through hospital pharmacies, outpatient clinics, and specialty pharmacies.

What Is The Cyfendus Market Growth Forecast?

The growth in the forecast period can be attributed to heightened biodefense investments, expansion of emergency response frameworks, increased public health funding, improved vaccine manufacturing capacity, stronger global security collaboration. Major trends in the forecast period include increased focus on biodefense vaccines, expansion of post exposure prophylaxis programs, government stockpiling of anthrax vaccines, rising integration of vaccines with antibiotic therapy, strengthening national emergency preparedness.

Global Cyfendus Market Segmentation

1) By Route Of Administration: Parenteral, Oral 2) By Clinical Indications: Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis, Special Populations 3) By Distribution Channel: Hospital Pharmacies, Outpatient Clinics, Specialty Pharmacies

What Are The Drivers Of The Cyfendus Market?

Increasing anthrax incidence is expected to drive the growth of the cyfendus market going forward. Anthrax incidence refers to the number of cases of anthrax reported within a specific population or geographic area over a defined period, indicating how frequently the disease occurs and helping public health authorities to gauge the risk and plan necessary preventive measures. Anthrax cases are rising due to increased human and animal interaction in endemic regions, environmental factors like disturbed soils releasing spores, and limited vaccination coverage in livestock populations. Cyfendus is required for anthrax to provide post-exposure protection by stimulating the immune system to produce antibodies against the anthrax bacteria when given in conjunction with antibiotics. For instance, in December 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, Zambia reported 684 suspected human cases of anthrax as of November 2023, including four fatalities, yielding a Case Fatality Ratio (CFR) of 0.6%. These cases have been spread across 44 of the country's 116 districts, with Sinazongwe district being the hardest hit, accounting for 287 cases (42% of the total) and two deaths (50% of the total fatalities). Therefore, the increasing anthrax incidence is driving the growth of the cyfendus industry. The rising healthcare investments are expected to boost the growth of the cyfendus market going forward. Healthcare investment refers to the allocation of financial resources into healthcare-related sectors, including medical research, pharmaceuticals, healthcare infrastructure, and technology, with the aim of improving public health outcomes and generating financial returns. Healthcare investment is rising due to increasing demand for innovative treatments, aging populations, advancements in medical technology, and the growing need for efficient healthcare systems to address global health challenges. Healthcare investment positively impacts Cyfendus by providing funding for the development, approval, and distribution of the vaccine, which is crucial for enhancing public health security and addressing rising health threats. For instance, in April 2025, according to the Office for National Statistics, a UK-based independent producer of official statistics, in 2024, the UK’s healthcare spending reached around £317 billion, reflecting a 6.5% nominal increase compared with 2023. Therefore, the rising healthcare investments are driving the growth of the cyfendus industry.

Key Players In The Global Cyfendus Market

Major companies operating in the cyfendus market are Emergent BioSolutions Inc.

Global Cyfendus Market Trends and Insights

Major companies operating in the cyfendus market are focusing on developing advanced solutions, such as post-exposure prophylactic vaccines, to enhance immune protection, reduce the risk of infection, and improve response in high-risk environments. Post-exposure prophylactic vaccines are medical preparations designed to stimulate the immune system to produce antibodies against Bacillus anthracis, either before or after exposure, thereby preventing the development of anthrax. For instance, in July 2023, Emergent BioSolutions Inc., a US-based biotechnology company, announced U.S. Food and Drug Administration (FDA) approval for CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted). The CYFENDUS vaccine is indicated for post-exposure prophylaxis in individuals aged 18 to 65 following suspected or confirmed exposure to Bacillus anthracis, when used alongside recommended antibiotics. Composed of Anthrax Vaccine Adsorbed (AVA) with an additional adjuvant, CYFENDUS has demonstrated protective immune responses in animal models of inhalational anthrax when administered in two doses over 14 days, which is crucial for managing large-scale public health emergencies involving anthrax.

Regional Insights

North America was the largest region in the cyfendus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Cyfendus Market?

The cyfendus market consists of sales of biodefense vaccines, antibiotics, autoinjectors, and vaccine adjuvants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cyfendus Market Report 2026?

The cyfendus market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cyfendus industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.